For one of our studies (non interventional, blood draw study), participants may be the Sub-Is or coordinators who are study team members. The IRB asked to describe precautions that will be taken to address any privacy, confidentiality, and overall consenting procedures related concerns. I am not really sure how to word this or what precautions to put in place. We already have a robust section in the Protocol addressing how all of the above will be protected and how consenting will be done. Any suggestions from previous experiences? This is the first time we encountered this situation.